Effect of withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients

Integrative Cancer Therapies

Volumn 12, Issue 4, 2013, Pages 312-322

  Biswal, Biswa Mohan ^a   Sulaiman, Siti Amrah ^a   Ismail, Hasanah Che ^a   Zakaria, Hasmat ^a   Musa, Kamarul Imran ^a  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

Author keywords

breast cancer; chemotherapy; fatigue; quality of life; Withania somnifera

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GRANISETRON; GRANULOCYTE COLONY STIMULATING FACTOR; ONDANSETRON; WITHANIA SOMNIFERA EXTRACT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED FATIGUE; CONTROLLED STUDY; FATIGUE; HUMAN; MAJOR CLINICAL STUDY; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; WITHANIA SOMNIFERA;

BREAST CANCER; CHEMOTHERAPY; FATIGUE; QUALITY OF LIFE; WITHANIA SOMNIFERA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FATIGUE; FEMALE; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; QUALITY OF LIFE; TREATMENT OUTCOME; WITHANIA;

EID: 84879326491     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735412464551     Document Type: Article

References (39)

1. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics:. CA Cancer J Clin. 2011 ; 61: 69-90
2. The First Report of the National Cancer Registry: Cancer Incidence in Malaysia 2002. Lim GCC Yahya H Lim TO, ed. Kuala Lumpur, Malaysia: National Cancer Registry ; 2003 :
3. Biswal BM, Kumaraswamy N, Mukhtar F. Prevalence of fatigue among cancer patients undergoing external radiotherapy. Southeast Asian J Trop Med Public Health. 2004 ; 35: 463-467
4. Piper BF, Cella D. Cancer related fatigue: definition and clinical subtypes. J Natl Compr Canc Netw. 2010 ; 8: 958-966
5. Piper BF, Dibbie SL, Dodd MJ, Weiss MC, Slaughter PE, Paul SM. The revised Piper's Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nursing Forum. 1998 ; 25: 667-684
6. Schwartz AL. The Schwartz Cancer Fatigue Scale: testing reliability and validity. Oncol Nurs Forum. 1998 ; 25: 711-717
7. Curt GA. The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist. 2000 ; 5: 9-12
8. National Cancer Institute. Fatigue (PDQ). http://www.cancer.gov/ cancertopics/pdq/supportivecare/fatigue/HealthProfessional/AllPages. Accessed June 30, 2011.
9. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic basis for the therapeutic use of Withania somnifera (Ashwagandha): a review. Altern Med Rev. 2000 ; 5: 334-346
10. Withania somnifera. Altern Med Rev. 2004 ; 9: 211-214
11. Kulkarni SK, Dhir A. Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. 2008 ; 32: 1093-1105
12. Gupta GL, Rana AC. Withania somnifera (Ashwagandha): a review. Pharmacol Rev. 2007 ; 1: 129-136
13. Mills S, Bone K Principles and Practice of Phytotherapy. Modern Herbal Medicine. Edinburgh, Scotland: Churchill Livingstone ; 514-602.
14. Schliebs R, Liebermann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian ginseng) and shilajit differentially affects cholinergic but not glutamatergic and GABAegic markers in rat brain. Neurochem Int. 1997 ; 30: 181-190
15. Mehta AK, Binkley P, Gandhi SS, Ticku MK. Pharmacological effects of Withania somnifera root extract on GABA receptor complex. Indian J Med Res. 1991 ; 94: 312-315
16. Katiyar CK, Brindavanam NB, Tiwari P, Narayana DBA Immunomodulation. Upadhyay SN, ed. New Delhi, India: Narosa ; 163-187.
17. Widodo N, Priyandoko D, Shah N, Wadhwa R, Kaul SC. Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involve ROS signaling. PLoS One. 2010 ; 5 (10). e13536
18. Devi PU. Withania somnifera Dunal (Ashwagandha): potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Indian J Exp Biol. 1996 ; 34: 927-932
19. Winters M. Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev. 2006 ; 11: 269-277
20. Jeyanthi T, Subramanian P. Nephroprotective effects of Withania somnifera: a dose-dependent study. Ren Fail. 2009 ; 31: 814-821
21. Gupta YK, Sharma SS, Rai K, Katiyar CK. Reversal of paclitaxel induced neutropenia by Withania somnifera in mice. Indian J Physiol Pharmacol. 2001 ; 45: 253-257
22. Ahmad M, Saleem S, Ahmad AS, et al. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol. 2005 ; 24: 137-147
23. Kumaraswamy N, Biswal BM, Mukhtar F, Chaturvedi SK. Screening for psychiatric morbidity in cancer patients in Malaysia. NIMHANS J. 2000 ; 18: 231-234
24. Prue G, Rankin J, Allen J, Gracey J, Cramp F. Cancer-related fatigue: a critical appraisal. Eur J Cancer. 2006 ; 42: 846-863
25. Miaskowski C, Portenoy RK. Update on the assessment and management of cancer related fatigue: principles and practice. Support Oncol Update. 1998 ; 1 (12). 1-10
26. Wanchai A, Armer JM, Stewart BR. Non-pharmacologic supportive strategies to promote quality-of-life in patients experiencing cancer related fatigue. Clin J Oncol Nurs. 2011 ; 15: 203-214
27. Bower JE, Garet D, Sternlieb B. Yoga for persistent fatigue in breast cancer survivors: result of a pilot study. Evid Based Complement Alternat Med. 2011 ; 2011: 623168
28. Montgomery GH, Kangas M, David D, et al. Fatigue during breast cancer radiotherapy: an initial randomized study of cognitive behavioral therapy plus hypnosis. Health Psychol. 2009 ; 28: 317-322
29. Singh A, Kulkarni SK. Effects of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food. 2002 ; 5: 211-220
30. Venkataraghavan S, Seshadri C, Sundaresan TP, Revathi R, Rajagopalan V, Janaki K. The comparative effect of milk fortified with ashwagandha, ashwagandha and punarnava in children: a double-blind study. J Res Ayurved Siddha. 1980 ; 1: 370-385
31. Davis L, Kuttan G. Suppressive effects of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J Ethnopharmacol. 1998 ; 62: 209-214
32. Roy AS, Acharya SB, De AK, Debnath PK. Khare CP. Mountain medicine: effect of Withania somnifera on the changes of phychophysiological status of trainee mountaineers by altitude gain. Paper presented at: International Seminar on Traditional Medicine ; 2004 Calcutta, India ; 2004..
33. Sandhu JS, Shah B, Shenoy S, Chauhan S, Lavekar GS, Padhi MM. Effects of Withania somnifera (ashwagandha) and terminal Arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. Int J Aurved Res. 2010 ; 1 (3). 144-149
34. Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D. Chemotherapeutic efficacy of paclitaxel with Withania somnifera on benzo(a)pyrene induced experimental lung cancer. Cancer Sci. 2006 ; 97: 658-664
35. Lee J, Hahm ER, Singh SV. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis. 2010 ; 31: 1991-1998
36. Hahm ER, Lee J, Huang Y, Singh SV. Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells. Mol Carcinog. 2011 ; 50: 614-624
37. McCune JS, Hatfield AJ, Blackburn AA, Leith PO, Livingston RB, Ellis GK. Potential of chemotherapy-herb interaction in adult cancer patients. Support Care Cancer. 2004 ; 12: 454-462
38. Meijerman I, Beijnen JH, Schellens JHM. Herb-drug interaction in oncology: focus on mechanisms of induction. Oncologist. 2006 ; 11: 742-752
39. Cheng CW, Fan W, Ko SG, Song L, Bian Z. Evidence-based management of herb-drug interaction in cancer chemotherapy. Explore (NY). 2010 ; 6: 324-329